AKT1 and hepatocellular carcinoma: Since RAS proteins are common upstream mediators of both RAF-ERK and PI3K-AKT-pathways, combinatory approaches targeting RAF/ERK- and PI3K/AKT-signaling could lead to major improvements in the management of HCC [28].